Zymosan activation of plasma reduces hypoxic pulmonary vasoconstriction
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Respiration Physiology
- Vol. 53 (3) , 295-306
- https://doi.org/10.1016/0034-5687(83)90121-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: Effect of an imidazole derivativeProstaglandins, 1982
- Digital integration of granulocyte aggregation responsesInflammation, 1980
- Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.Journal of Clinical Investigation, 1979
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.Journal of Clinical Investigation, 1977
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977
- Complement and Leukocyte-Mediated Pulmonary Dysfunction in HemodialysisNew England Journal of Medicine, 1977
- Prostaglandin E1 inhibits the pulmonary vascular pressor response to hypoxia and prostaglandin F2αProstaglandins, 1975
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDE: CONSUMPTION OF EACH OF THE SIX TERMINAL COMPLEMENT COMPONENTSThe Journal of Experimental Medicine, 1968
- The Properdin System and Immunity: I. Demonstration and Isolation of a New Serum Protein, Properdin, and Its Role in Immune PhenomenaScience, 1954